MOUNJARO KWIKPEN 15 mg (Tirzepatide)

Prescription Mandatory

Mounjaro KwikPen 15 mg contains tirzepatide, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It works by activating GIP and GLP-1 receptors to enhance insulin secretion and reduce appetite.

Manufacturer	Eli Lilly and Company
Generic Name	Tirzepatide
Strength	15mg
Package size	1 pre-filled 2.4 ml pen
Used for	Type 2 diabetes and weight control
Availability	In Stock
Shipping to	USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries.

Ask Price on WhatsApp

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support

Uses of MOUNJARO KWIKPEN 15 mg

Treats type 2 diabetes mellitus.
Helps in obesity management.
Used for improving insulin control.
Supports diet and exercise therapy.

Benefits of MOUNJARO KWIKPEN 15 mg

Strong glucose-lowering effect.
Supports significant weight reduction.
Reduces appetite and cravings.
Improves metabolic function.
Helps lower long-term complications.

How Does It Work?

Tirzepatide is a dual incretin agonist that activates GLP-1 and GIP receptors. This improves insulin release, reduces glucagon, slows digestion, and decreases appetite, leading to better sugar and weight control.

Precautions

Use once-weekly injection as directed.
Follow proper dosing schedule.
Monitor blood sugar frequently.
Inform doctor about thyroid or pancreatic disease.
Stay hydrated during treatment.
Report severe gastrointestinal symptoms.
Avoid alcohol excess.
Attend regular follow-ups.

Side Effects

Nausea
Vomiting
Diarrhea
Decreased appetite
Constipation